Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related JNJ
Achillion Announces Janssen Initiated Phase I Study to Evaluate Effect of Simeprevir and Odalasvir on AL-335 Pharmacokinetics
S&P 500 Index Futures Trading Higher
Scanning The SA Family For Alpha: AceSwat (Seeking Alpha)
Related ILMN
Morning Market Losers
Benzinga's Top #PreMarket Losers
Premarket Biotech Digest: Gilead HIV, Eliquis Trial Errors, Clinical Trial Phases (Seeking Alpha)

Analysts at Deutsche Bank upgraded Johnson & Johnson (NYSE: JNJ) from “hold” to “buy.” Johnson & Johnson's stock closed at $70.74 yesterday. Johnson & Johnson had $19.77 billion in total cash for the latest quarter.

Piper Jaffray upgraded Illumina (NASDAQ: ILMN) from “neutral” to “overweight.” Illumina's shares closed at $55.55 yesterday. Illumina's PEG ratio is 2.02.

Analysts at Janney Capital upgraded Target (NYSE: TGT) from “neutral” to “buy.” Target's shares closed at $60.16 yesterday. Target's trailing-twelve-month revenue is $71.86 billion.

Needham upgraded Mattel (NASDAQ: MAT) from “hold” to “buy.” Mattel's shares closed at $36.72 yesterday. Mattel's trailing-twelve-month operating margin is 18.67%.

Latest Ratings for JNJ

DateFirmActionFromTo
May 2015JefferiesMaintainsHold
May 2015Deutsche BankMaintainsHold
Apr 2015Deutsche BankMaintainsHold

View More Analyst Ratings for JNJ
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (ILMN + JNJ)

Get Benzinga's Newsletters